T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)
about
PHF6 mutations in T-cell acute lymphoblastic leukemiaPopulation mixing for leukaemia, lymphoma and CNS tumours in teenagers and young adults in England, 1996-2005.Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs.Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors.Impact of Aberrant Myeloid Antigen Expression on Outcomes of Patients with T-cell Acute Lymphoblastic LeukemiaInterleukin-7 receptor-α gene mutations are not detected in adult T-cell acute lymphoblastic leukemia.Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemiaThe indicative effect of Notch1 expression for the prognosis of T-cell acute lymphocytic leukemia: a systematic review.ETV6 mutations in early immature human T cell leukemiasCD30 expression in acute lymphoblastic leukemia as assessed by flow cytometry analysis.Indolent T-lymphblastic proliferation: report of a case involving the upper aerodigestive tractInterleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progressionContrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia.Role of allogeneic hematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukemia.Regulation of Src family kinases involved in T cell receptor signaling by protein-tyrosine phosphatase CD148.Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.Mutational spectrum of adult T-ALLMutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutationsT cell acute lymphoblastic leukaemia presenting with sudden onset right oculomotor nerve palsy with normal neuroradiography and cerebrospinal fluid studiesCD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900.Effects of Toll-like receptor signals in T-cell neoplasms.HSP90 inhibition leads to degradation of the TYK2 kinase and apoptotic cell death in T-cell acute lymphoblastic leukemiaTYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemiaThe clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial.The TCA cycle transferase DLST is important for MYC-mediated leukemogenesis.Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia.Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytesThe prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest.Primary thyroid T-lymphoblastic lymphoma: a case report and review of the literature.Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia.Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLIOverexpression of SLC25A38 protein on acute lymphoblastic leukemia cells.Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia.Treatment of acute lymphoblastic leukemia in adolescents and young adults.Optimal pharmacotherapeutic management of acute lymphoblastic leukaemia in the elderly.The role of allogeneic hematopoietic stem cell transplantation in the therapy of patients with acute lymphoblastic leukemia.Recent developments in the management of T-cell precursor acute lymphoblastic leukemia/lymphoma.Hypoxia regulates the hematopoietic stem cell niche.
P2860
Q29394463-C6CBC06A-DD32-4917-9BE3-560FF1F3D456Q30390600-B642F265-728F-4FE6-BC49-BB9DA0D1B960Q31085503-6010412E-50C7-4F51-BEAE-7D5055BC2BB5Q33558120-0D9ABB92-39B2-42E4-BB06-69D69C5F8440Q33736847-46720D2B-4737-4C5A-AE87-DE20C76D5577Q33913531-80B8F92A-0349-46F4-BDD2-EC7AC4F23B58Q34131813-CF321EEF-A7B9-44A7-A4C3-2754A5A877BAQ34152237-C8AC3309-2CDE-490A-A7BA-9DF3F21034BAQ34240267-5442B604-3D7A-4B0E-93B9-AF8DBC0646A8Q34300704-A39AAA52-DEBD-46EA-BEF5-1B0C2E4A6743Q34371810-E7E459F1-97AB-42C3-8425-91EFEF14CDD1Q34372296-C147978D-A76C-4706-ADEB-DAAADB9FD678Q34403179-784923F2-F35B-43D8-B1A4-4BD2687F8F30Q34532041-93A951FD-0ED9-4180-9B52-F10B5EA3021DQ35063027-8DA53B0E-ACCF-4035-A895-5411FA5D846AQ35199893-747F091E-2643-46C4-8881-E3A60EBD6EEDQ35550090-31AEA984-CE10-4122-83F1-913A68AEBE1EQ35596924-E04C4118-61C5-4735-B326-8D94061D2EAEQ35723764-86CC649E-66B5-4337-B802-3945857A4DD2Q35863508-3A78C0A5-8F73-43F2-BDCB-2A2E3280F43BQ36249453-68718257-1702-4D25-A143-2DC829B9CC03Q36293678-DDD2890A-356C-4056-B0DF-060A4699294BQ36436934-70B662B5-FE98-4F67-AB7F-6F56B44BC0A4Q36836799-42EC04CB-DBE5-49DD-B96D-2E1186C766AFQ36892609-AA1FD91D-E9CA-4FF9-8816-AF85119564E5Q36957835-433FB677-3119-4617-B2D3-A0C2D514D8ECQ36983745-1268F732-E8D2-4733-B818-3E42930B26DBQ37026039-20634D8E-663D-42E4-9764-B4E0300F7DFEQ37226729-40BA9977-1E43-471D-B4B1-F2C34B6CC7C1Q37273178-4218299B-7BC3-40CF-98E6-AB45EDD2636AQ37452398-EBE107BE-9DFB-434C-9472-E52B2A24830EQ37524180-8A9C66A7-D7E8-4380-A78C-C9C06841D884Q37536445-AD2F769A-5F9B-4387-AB04-03101666A313Q37719992-22F8AA79-1278-4A1C-A677-6F4A3F24393AQ37802059-E351E6A8-779B-40F0-8A02-73F9B62A5258Q37899785-6787F8EF-D9D0-475A-8A19-A8B8143A6F60Q37931235-5DAFD90A-8B9B-4B43-B9B2-8AAE02C2B06EQ37992837-BD6DE3F7-630B-4265-AF4F-10E546A0C520Q38000087-00179DED-4D59-4E3F-AF5F-5C2DF732E2F4Q38613531-DF9B0E0E-3917-4794-A60C-215518FA578C
P2860
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
T-cell acute lymphoblastic leu ...... ve trial (UKALL XII/ECOG 2993)
@ast
T-cell acute lymphoblastic leu ...... ve trial (UKALL XII/ECOG 2993)
@en
T-cell acute lymphoblastic leu ...... ve trial (UKALL XII/ECOG 2993)
@nl
type
label
T-cell acute lymphoblastic leu ...... ve trial (UKALL XII/ECOG 2993)
@ast
T-cell acute lymphoblastic leu ...... ve trial (UKALL XII/ECOG 2993)
@en
T-cell acute lymphoblastic leu ...... ve trial (UKALL XII/ECOG 2993)
@nl
prefLabel
T-cell acute lymphoblastic leu ...... ve trial (UKALL XII/ECOG 2993)
@ast
T-cell acute lymphoblastic leu ...... ve trial (UKALL XII/ECOG 2993)
@en
T-cell acute lymphoblastic leu ...... ve trial (UKALL XII/ECOG 2993)
@nl
P2093
P2860
P50
P1433
P1476
T-cell acute lymphoblastic leu ...... ve trial (UKALL XII/ECOG 2993)
@en
P2093
Adele K Fielding
Adolfo Ferrando
Andrew K McMillan
Anthony H Goldstone
David I Marks
Elisabeth M Paietta
Gordon DeWald
Hillard M Lazarus
Jacob M Rowe
Mark R Litzow
P2860
P304
P356
10.1182/BLOOD-2009-08-231217
P407
P577
2009-12-01T00:00:00Z